DE SANTIS, SARA
 Distribuzione geografica
Continente #
EU - Europa 159
NA - Nord America 154
AS - Asia 41
AF - Africa 1
Totale 355
Nazione #
US - Stati Uniti d'America 153
IT - Italia 71
IE - Irlanda 20
FR - Francia 19
IN - India 18
DE - Germania 14
GB - Regno Unito 8
BG - Bulgaria 6
ID - Indonesia 6
SE - Svezia 5
CN - Cina 4
FI - Finlandia 4
AT - Austria 3
IQ - Iraq 3
IR - Iran 3
CZ - Repubblica Ceca 2
HK - Hong Kong 2
KR - Corea 2
NL - Olanda 2
PK - Pakistan 2
CA - Canada 1
DK - Danimarca 1
ES - Italia 1
GR - Grecia 1
PH - Filippine 1
RS - Serbia 1
UA - Ucraina 1
ZA - Sudafrica 1
Totale 355
Città #
Dublin 20
Ashburn 19
Bologna 12
Santa Cruz 12
Turin 12
Rome 9
Milan 7
Seattle 7
Buffalo 6
Chicago 6
Mountain View 6
Redmond 6
Sofia 5
Boardman 4
Cambridge 4
Houston 4
Jakarta 4
Lucknow 4
Southend 4
Ahmedabad 3
Basrah 3
Bremen 3
Council Bluffs 3
Fairfield 3
Francofonte 3
Helsinki 3
Khambhat 3
Malmo 3
Paris 3
San Diego 3
Vienna 3
Ann Arbor 2
Birmingham 2
Catania 2
Central 2
Columbus 2
Delhi 2
Gorle 2
Henderson 2
Kediri 2
Lund 2
Modena 2
New York 2
San Giovanni Teatino 2
Shanghai 2
Spoleto 2
Tianjin 2
Wilmington 2
Woodbridge 2
Wyncote 2
Zahedan 2
Agios Dimitrios 1
Andover 1
Arnhem 1
Atlanta 1
Badia Polesine 1
Barcelona 1
Berlin 1
Brooklyn 1
Büdelsdorf 1
Cascina 1
Changwon 1
Cirié 1
Dulles 1
East Brunswick 1
Frankfurt Am Main 1
Hillsboro 1
Horsens 1
Islamabad 1
Kangayam 1
Lappeenranta 1
Las Vegas 1
Lincoln 1
London 1
Los Angeles 1
Maastricht 1
Malvern 1
Miami 1
Muizenberg 1
Mumbai 1
Munich 1
Olongapo City 1
Ottawa 1
Pilsen 1
Piscataway 1
Plovdiv 1
Portland 1
Provo 1
Pune 1
Saluzzo 1
Sargodha 1
Savigliano 1
Scranton 1
Secaucus 1
Seoul 1
Svilajnac 1
Tehran 1
Udine 1
Vellore 1
Woking 1
Totale 276
Nome #
Targeting leukemic stem cells in chronic myeloid leukemia: Is it worth the effort?, file e1dcb339-789d-7715-e053-1705fe0a6cc9 122
Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors, file e1dcb332-e6a2-7715-e053-1705fe0a6cc9 62
Recent advances in the molecular biology of systemic mastocytosis: Implications for diagnosis, prognosis, and therapy, file e1dcb336-757a-7715-e053-1705fe0a6cc9 61
Case Report: A Novel Activating FLT3 Mutation in Acute Myeloid Leukemia, file e1dcb338-75ea-7715-e053-1705fe0a6cc9 34
Combined Inhibition of Polo-like Kinase-1 and Wee1 as a New Therapeutic Strategy to Induce Apoptotic Cell Death in Neoplastic Mast Cells, file e1dcb339-133c-7715-e053-1705fe0a6cc9 32
Polo-like kinase-1, Aurora kinase A and WEE1 kinase are promising druggable targets in CML cells displaying BCR::ABL1-independent resistance to tyrosine kinase inhibitors, file 8c4fbec8-d0ba-46ea-ac30-2cf21af6879a 19
Overcoming Resistance to Kinase Inhibitors: The Paradigm of Chronic Myeloid Leukemia, file e1dcb339-6a6b-7715-e053-1705fe0a6cc9 15
The role of hypoxic bone marrow microenvironment in acute myeloid leukemia and future therapeutic opportunities, file e1dcb338-9493-7715-e053-1705fe0a6cc9 9
Combined Inhibition of Polo-like Kinase-1 and Wee1 as a New Therapeutic Strategy to Induce Apoptotic Cell Death in Neoplastic Mast Cells, file e1dcb339-bce2-7715-e053-1705fe0a6cc9 4
Prognosis in Chronic Myeloid Leukemia: Baseline Factors, Dynamic Risk Assessment and Novel Insights, file 902efd85-6eb6-494c-b53b-132bf388035b 3
MPN-182 Droplet Digital PCR for Non-Invasive Detection of the KIT D816V Mutation in the Peripheral Blood of Patients With Suspected Systemic Mastocytosis, file 44547b71-147a-4fd7-93db-0f72c542d773 1
SETD2 non genomic loss of function in advanced systemic mastocytosis is mediated by an Aurora kinase A/MDM2 axis and can be therapeutically targeted, file 627ee662-ed79-4973-98c1-01e0759de48c 1
Totale 363
Categoria #
all - tutte 1.418
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.418


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205 0 0 0 0 0 0 0 0 0 2 1 2
2020/202133 1 2 1 0 1 1 1 3 4 5 12 2
2021/202249 1 1 1 2 2 4 1 2 2 6 18 9
2022/2023139 2 4 9 13 8 3 3 6 33 20 23 15
2023/2024137 13 16 12 17 12 20 7 11 10 12 7 0
Totale 363